These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 9610733

  • 1. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L, Murphy GF, Béliveau R.
    Int J Cancer; 1998 May 29; 76(5):729-37. PubMed ID: 9610733
    [Abstract] [Full Text] [Related]

  • 2. Interaction of drugs with P-glycoprotein in brain capillaries.
    Jetté L, Murphy GF, Leclerc JM, Beliveau R.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1701-9. PubMed ID: 7503774
    [Abstract] [Full Text] [Related]

  • 3. P-glycoprotein is a dimer in the kidney and brain capillary membranes: effect of cyclosporin A and SDZ-PSC 833.
    Jetté L, Potier M, Béliveau R.
    Biochemistry; 1997 Nov 11; 36(45):13929-37. PubMed ID: 9374872
    [Abstract] [Full Text] [Related]

  • 4. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein.
    Pétriz J, Sánchez J, Bertrán J, García-López J.
    Anticancer Drugs; 1997 Oct 11; 8(9):869-75. PubMed ID: 9402314
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T, Uchiyama N, Roninson IB, Cohen D, Atadja P.
    Int J Oncol; 2000 Sep 11; 17(3):579-86. PubMed ID: 10938401
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.
    Döppenschmitt S, Spahn-Langguth H, Regårdh CG, Langguth P.
    Pharm Res; 1998 Jul 11; 15(7):1001-6. PubMed ID: 9688051
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I, Swatonek H, Schaufler K, Ulsperger E, Wenzl E, Theyer G, Hamilton G, Thalhammer T.
    Int J Oncol; 1998 May 11; 12(5):1137-42. PubMed ID: 9538140
    [Abstract] [Full Text] [Related]

  • 13. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
    den Boer ML, Pieters R, Kazemier KM, Janka-Schaub GE, Henze G, Veerman AJ.
    Leukemia; 1998 Jun 11; 12(6):912-20. PubMed ID: 9639420
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
    De Rosa MF, Ackerley C, Wang B, Ito S, Clarke DM, Lingwood C.
    J Biol Chem; 2008 Feb 22; 283(8):4501-11. PubMed ID: 18003606
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR, Kelsey SM, Wu YL, Newland AC.
    Br J Haematol; 1995 Jun 22; 90(2):375-83. PubMed ID: 7794760
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporin A has low potency as a calcineurin inhibitor in cells expressing high levels of P-glycoprotein.
    Fakata KL, Elmquist WF, Swanson SA, Vorce RL, Prince C, Stemmer PM.
    Life Sci; 1998 Jun 22; 62(26):2441-8. PubMed ID: 9651111
    [Abstract] [Full Text] [Related]

  • 18. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
    Pilarski LM, Yatscoff RW, Murphy GF, Belch AR.
    Leukemia; 1998 Apr 22; 12(4):505-9. PubMed ID: 9557608
    [Abstract] [Full Text] [Related]

  • 19. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
    Ferry D, Boer R, Callaghan R, Ulrich WR.
    Int J Clin Pharmacol Ther; 2000 Mar 22; 38(3):130-40. PubMed ID: 10739116
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of ecto-5'-nucleotidase promotes P-glycoprotein expression in renal epithelial cells.
    Ledoux S, Leroy C, Siegfried G, Prie D, Moullier P, Friedlander G.
    Kidney Int; 1997 Oct 22; 52(4):953-61. PubMed ID: 9328934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.